Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 300 Mcg (0.3 Mg), 90-count Bottles

Levothyroxine Recall Summary Accord Healthcare is recalling 300 mcg levothyroxine sodium tablets (90-count bottles) distributed nationwide because the medication contains less active ingredient than labeled. This thyroid medication was manufactured by Intas Pharmaceuticals Limited in India and distributed across all U.S. states. People who filled prescriptions for this specific product may have received tablets that don't provide the full intended dose.

Recalling firm

ACCORD HEALTHCARE, INC.

Product

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-08-06

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide within the United States

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/d0843287-6cc5-4db6-8e2b-f551dad96566